Literature DB >> 34003477

Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.

Yuhan Yang1, Xuelei Ma2, Yixi Wang1, Xinyan Ding1.   

Abstract

Many researches have applied machine learning methods to find associations between radiomic features and clinical outcomes. Random survival forests (RSF), as an accurate classifier, sort all candidate variables as the rank of importance values. There was no study concerning on finding radiomic predictors in patients with extremity and trunk wall soft-tissue sarcomas using RSF. This study aimed to determine associations between radiomic features and overall survival (OS) by RSF analysis. To identify radiomic features with important values by RSF analysis, construct predictive models for OS incorporating clinical characteristics, and evaluate models' performance with different method. We collected clinical characteristics and radiomic features extracted from plain and contrast-enhanced computed tomography (CT) from 353 patients with extremity and trunk wall soft-tissue sarcomas treated with surgical resection. All radiomic features were analyzed by Cox proportional hazard (CPH) and followed RSF analysis. The association between radiomics-predicted risks and OS was assessed by Kaplan-Meier analysis. All clinical features were screened by CPH analysis. Prognostic clinical and radiomic parameters were fitted into RSF and CPH integrative models for OS in the training cohort, respectively. The concordance indexes (C-index) and Brier scores of both two models were evaluated in both training and testing cohorts. The model with better predictive performance was interpreted with nomogram and calibration plots. Among all 86 radiomic features, there were three variables selected with high importance values. The RSF on these three features distinguished patients with high predicted risks from patients with low predicted risks for OS in the training set (P < 0.001) using Kaplan-Meier analysis. Age, lymph node involvement and grade were incorporated into the combined models for OS (P < 0.05). The C-indexes in both two integrative models fluctuated above 0.80 whose Brier scores maintained less than 15.0 in the training and testing datasets. The RSF model performed little advantages over the CPH model that the calibration curve of the RSF model showed favorable agreement between predicted and actual survival probabilities for the 3-year and 5-year survival prediction. The multimodality RSF model including clinical and radiomic characteristics conducted high capacity in prediction of OS which might assist individualized therapeutic regimens. Level III, prognostic study.
© 2021. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Cox proportional hazard; Nomogram; Prognosis; Radiomics; Random survival forests; Soft-tissue sarcoma; Texture analysis

Mesh:

Year:  2021        PMID: 34003477     DOI: 10.1007/s13304-021-01074-8

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  2 in total

1.  An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Authors:  Haley Gittleman; Daniel Lim; Michael W Kattan; Arnab Chakravarti; Mark R Gilbert; Andrew B Lassman; Simon S Lo; Mitchell Machtay; Andrew E Sloan; Erik P Sulman; Devin Tian; Michael A Vogelbaum; Tony J C Wang; Marta Penas-Prado; Emad Youssef; Deborah T Blumenthal; Peixin Zhang; Minesh P Mehta; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

2.  Magnetic Resonance Imaging-guided Brachytherapy Re-irradiation for Isolated Local Recurrence of Soft Tissue Sarcoma.

Authors:  Noelia Sanmamed; Alejandro Berlin; Akbar Beiki-Ardakani; Heather Ballantyne; Anna Simeonov; Peter Chung
Journal:  Cureus       Date:  2018-04-10
  2 in total
  1 in total

1.  Nomograms predicting local and distant recurrence and disease-specific mortality for R0/R1 soft tissue sarcomas of the extremities.

Authors:  Rita De Sanctis; Renata Zelic; Armando Santoro
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.